Papillomavirus-like particles and HPV vaccine development.
about
Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitopePapillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses.Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.Social values and scientific evidence: the case of the HPV vaccines.Collection of cervical secretions does not adversely affect Pap smears taken immediately afterwardEpidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.Human papillomavirus: clinical significance and malignant potential.Papillomavirus-like particle based vaccines: cervical cancer and beyond.Genotype distribution of human papillomavirus (HPV) in histological sections of cervical intraepithelial neoplasia and invasive cervical carcinoma in Madrid, Spain.HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions.Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists.Vaccines that facilitate antigen entry into dendritic cells.Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected childrenPrevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping testHuman papillomavirus infection with particular reference to genital disease.Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.Prevalence of human papillomavirus genotypes in women with cervical cancer in Papua New Guinea.Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization.Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro
P2860
Q24796150-64D4E81D-BD1F-4EAC-901A-B1721459E7E8Q33847557-56E5E268-C6A5-4EEA-9253-CFE2B9BD9EBBQ33853398-2A69546C-28DF-4BE6-8C7F-6E0CA48715E9Q33890189-C7611B2D-1A13-4B9F-BFC6-949FF55657DCQ33997343-AE1BDDA5-BE85-4A4F-A390-865A8494F292Q34267472-D0BC8DD6-D7E2-49D9-87A6-F846D8BB2605Q34394146-EC72B7D1-0E7F-4D3E-8CBC-29042C7E804FQ34451862-EC4783AA-DDA6-4AA1-8565-45C8A3D5020FQ34483573-978C1B6B-A736-4D88-AC2A-79792F505182Q34507291-C99ADFF4-77A3-49EF-AFCC-FCBDEDBA9080Q35614621-512E171A-1367-48A0-BFA1-DCAA57685953Q35915763-0C0CD609-5B3C-4E3C-9434-5CA0990F3881Q36486823-47711324-B23C-4F78-A4B6-0894F353D60CQ36587825-561A2B75-81B9-42B8-8E7D-1E49F6A93859Q37227138-24A29ACA-D98E-486B-AB08-8EA456A61FFFQ37511451-3BCBEAC4-DE0B-4814-A50E-16F98B1BD251Q46691284-73D1F333-95B4-45D0-8DFB-724368DF68DBQ55627667-DCDEF634-D77D-4BCB-A9BC-F468765D2866Q55689231-64D144C4-61D1-4935-BF89-C77DA11A77D2Q58696384-F01930CD-1903-44A4-B7E4-CED2F0765DA6
P2860
Papillomavirus-like particles and HPV vaccine development.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Papillomavirus-like particles and HPV vaccine development.
@en
type
label
Papillomavirus-like particles and HPV vaccine development.
@en
prefLabel
Papillomavirus-like particles and HPV vaccine development.
@en
P356
P1476
Papillomavirus-like particles and HPV vaccine development.
@en
P2093
P304
P356
10.1006/SCBI.1996.0046
P577
1996-12-01T00:00:00Z